Author

Rachel West 1

1 Sint Franciscus Gasthuis,Rotterdam,Netherlands

CLINICAL OUTCOMES OF INCREASED VERSUS CONVENTIONAL ADALIMUMAB DOSE INTERVALS IN PATIENTS WITH CROHN’S DISEASE IN STABLE REMISSION: THE RANDOMISED CONTROLLED LADI TRIAL

Reinier C. A. van Linschoten, Fenna Minke Jansen, Renske W. M. Pauwels, Lisa J. T. Smits, Femke Atsma, Wietske Kievit, Paul Boekema, Rachel West, Alexander G. L. Bodelier, Ingrid A. M. Gisbertz, Frank H. J. Wolfhagen, Tessa E. H. Römkens, Maurice W. M. D. Lutgens, Adriaan A. Van Bodegraven, Bas Oldenburg, Marieke Pierik, Ma

DE-ESCALATION OF BIOLOGICAL THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS FOLLOWING PRIOR ESCALATION

Maurice Russel, Pepijn Thomas, Maarten te Groen, Rachel West, Lisa S. Smits, Jeroen Michiel Jansen, Frank Hoentjen, Tessa E.H. Römkens

HIGH DOSE VITAMIN D DOES NOT PREVENT POSTOPERATIVE ENDOSCOPIC AND CLINICAL RECURRENCE IN CROHN'S DISEASE

Jessica R. de Bruyn, Peter Bossuyt, Marc Ferrante, Rachel West, Gerard Dijkstra, Ben J. Witteman, Denis Franchimont, Jarmila D. van der Bilt, Tim Tollens, Willem A. Bemelman, André D'Hoore, Marjolijn Duijvestein, Geert R. D'Haens

IMPROVED WORK PRODUCTIVITY IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH MESALAZINE IN ROUTINE CLINICAL PRACTICE IN THE NETHERLANDS: RESULTS FROM THE IMPACT STUDY

Rachel West, Johan Kuijvenhoven, Maurice Russel, Alexander Bodelier, Karlien F. Bruin, Peter van Winkel

LONG-TERM HEALTH OUTCOMES OF 1000 CHILDREN BORN TO MOTHERS WITH INFLAMMATORY BOWEL DISEASE IN THE ANTI-TNF ERA

Shannon Kanis, Sanne Modderman, Johanna Caroline Escher, Ruud Beukers, K.H.N. (Nanne) de Boer, Alexander Bodelier, ACTM Depla, Gerard Dijkstra, Anne-Baue Van Dijk, Lennard P.L. Gilissen, Frank Hoentjen, Jeroen Michiel Jansen, Johannes Kuijvenhoven, Nofel Mahmmod, R. Mallant, Andrea E. Van Der Meulen - De Jong, Anahita Noruz

LOWER RISK OF RECURRENCE WITH A HIGHER INDUCTION DOSE OF MESALAZINE AND LONGER DURATION OF TREATMENT IN ULCERATIVE COLITIS: RESULTS FROM THE DUTCH, NON-INTERVENTIONAL, IMPACT STUDY

Rachel West

LOWER RISK OF RECURRENCE WITH A HIGHER INDUCTION DOSE OF MESALAZINE AND LONGER DURATION OF TREATMENT IN ULCERATIVE COLITIS: RESULTS FROM THE DUTCH, NON-INTERVENTIONAL, IMPACT STUDY

Rachel West, Johan Kuijvenhoven, Maurice Russel, Alexander Bodelier, Karlien F. Bruin, Peter van Winkel

MONITORING OF  LABORATORY PARAMETERS DURING THIOPURINE MAINTENANCE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: AN UNNECESSARY BURDEN?

Joany Ellis Kreijne, Annemarie C. De Vries, Gerd Bouma, Gerard Dijkstra, Rachel West, Marieke J. Pierik, Dirk J. De Jong, Nanne Karel Hendrik de Boer, C. Janneke van der Woude

POSTOPERATIVE PROPHYLACTIC THIOPURINES OR BIOLOGICALS ARE PROTECTIVE FOR CLINICAL AND ENDOSCOPIC RECURRENCE AT SHORT TERM FOLLOW-UP AFTER PRIMARY ILEOCECAL RESECTION IN CROHN'S DISEASE, BUT NOT ASSOCIATED WITH A LONG-TERM BENEFICIAL EFFECT ON THE RISK OF RE-RESECTION

Jeanine Arkenbosch, Evelien M.J. Beelen, Frank Hoentjen, Alexander Bodelier, Gerard Dijkstra, Marielle Romberg-Camps, K.H.N. (Nanne) de Boer, Laurents Stassen, Andrea E. Van Der Meulen - De Jong, Rachel West, Oddeke van Ruler, Janneke van der Woude, Annemarie De Vries

REAL-WORLD IMPACT OF BIOLOGICAL THERAPIES ON WORK IMPAIRMENT AND QUALITY OF LIFE IN INFLAMMATORY BOWEL DISEASE PATIENTS

Pepijn Thomas, Nathan den Broeder, Rachel West, Maurice Russel, Tessa E.H. Römkens, Frank Hoentjen, Jeroen Michiel Jansen

Item 1 - 10 / 13
1
2